Immungenetics AG - Research for Patients

Immungenetics AG has the aim to implement research results regarding the genetic basis of immune response as well as neurodegeneration, i.e. to develop and market diagnostic tests and similar services for immune mediated diseases such as multiple sclerosis or rheumatoid arthritis as well as neurodegenerative diseases, e. g. M. Alzheimer and M. parkinson.

As the causes for these immune mediated and neurodegenerative diseases have not yet been fully clarified these diseases are currently not curable and the suitable therapy is to be found empirically.

Our goal is to make predictions on the course of a disease by means of genetic associations, i.e. based on the individual genome of a patient, and thus allow for an individual therapy and medication.

Immungenetics AG is certified according to DIN EN ISO 9001 and DIN EN ISO 13485.

Certified

Pipeline

Immungenetics AG

Immungenetics AG
Prof. Dr. med. Saleh Ibrahim
 
www.innoveas.com